Published in Schizophr Res on September 01, 2004
Cognitive function and symptoms in adolescents with schizotypal personality disorder. Schizophr Bull (2006) 0.91
Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review. J Addict Dis (2009) 0.80
Deficient visual sensitivity in schizotypal personality disorder. Schizophr Res (2010) 0.78
Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder. Schizophr Res (2012) 0.77
Pituitary volume in schizophrenia spectrum disorders. Schizophr Res (2013) 0.75
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry (2011) 4.29
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry (2006) 4.18
No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry (2008) 3.23
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry (2003) 3.14
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry (2002) 2.75
Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex (2004) 2.66
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry (2007) 2.60
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 2.06
The Internet-based MGS2 control sample: self report of mental illness. Am J Psychiatry (2010) 2.05
Borderline personality disorder. Lancet (2011) 2.01
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry (2002) 2.01
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement (2008) 1.90
Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet (2006) 1.89
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry (2002) 1.84
The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry (2002) 1.81
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophr Res (2005) 1.73
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 1.71
Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology (2007) 1.70
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Am J Geriatr Psychiatry (2005) 1.66
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet (2007) 1.65
Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry (2005) 1.63
Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clin Neuropharmacol (2005) 1.61
No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57
White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry (2005) 1.56
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci (2005) 1.55
Patterns of stress in schizophrenia. Psychiatry Res (2008) 1.55
Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology (2007) 1.54
Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain (2010) 1.50
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry (2003) 1.49
Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab (2009) 1.49
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. J Am Med Dir Assoc (2004) 1.48
Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. J Nucl Med (2002) 1.43
Decreased absolute amygdala volume in cocaine addicts. Neuron (2004) 1.41
DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry (2006) 1.41
Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry (2004) 1.40
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) (2004) 1.38
Abuse and neglect in childhood: relationship to personality disorder diagnoses. CNS Spectr (2003) 1.38
Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res (2007) 1.36
Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res (2011) 1.36
Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res (2009) 1.34
Neural correlates of using distancing to regulate emotional responses to social situations. Neuropsychologia (2010) 1.33
Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder. J Psychiatr Res (2009) 1.32
Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain (2006) 1.31
An analysis of candidate autism loci on chromosome 2q24-q33: evidence for association to the STK39 gene. Am J Med Genet B Neuropsychiatr Genet (2008) 1.31
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. J Clin Endocrinol Metab (2002) 1.30
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale. Personal Disord (2011) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele. Am J Geriatr Psychiatry (2008) 1.28
The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry (2009) 1.28
Personality disorder types proposed for DSM-5. J Pers Disord (2011) 1.27
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry (2002) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Cardiovascular risk factors for Alzheimer's disease. Am J Geriatr Cardiol (2007) 1.24
Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry (2005) 1.23
Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry (2005) 1.22
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry (2002) 1.22
Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder. Biol Psychiatry (2009) 1.21
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. Schizophr Res (2008) 1.20
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Gender differences in the motivational processing of babies are determined by their facial attractiveness. PLoS One (2009) 1.18
Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res (2009) 1.18
The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry (2003) 1.17